Nachrichten zur AstraZeneca PLC Aktie

AstraZeneca: Contrarian Buy After The China Challenge (Rating Upgrade)

…

AstraZeneca Says Current, Former Executives Involved in China Probe

Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe…

AstraZeneca Aktie: Kursrückgang übertrieben

Toronto (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von BMO Capital Markets: 1. Überblick über die Situation AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol: ZEG, London…

ANALYSE-FLASH: Deutsche Bank Research hebt Astrazeneca auf Hold

FRANKFURT (dpa-AFX) - Deutsche Bank Research hat Astrazeneca bei einem unveränderten Kursziel von 10500 Pence von "Sell" auf "Hold"…

ANALYSE-FLASH: Deutsche Bank Research hebt Astrazeneca auf 'Hold'

FRANKFURT (dpa-AFX) - Deutsche Bank Research hat Astrazeneca bei einem unveränderten Kursziel von 10500 Pence…

AstraZeneca Aktie: China-Bedenken übertrieben - Kursrückgang als Kaufchance!

Charlotte (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von BofA Securities: Aktuelle Bewertung Die Analysten von BofA Securities stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292,…

Buy, Sell, or Hold AstraZeneca Stock? Key Tips Ahead of Q3 Earnings

AstraZenecas key medicines, mainly cancer drugs, Lynparza, Tagrisso and Imfinzi, and diabetes medicine Farxiga are expected to have driven the…

AstraZeneca shares fall on report of potential China probe fallout

AstraZeneca shares recorded their worst day since March 2020.…

FIVE at FIVE: Primark profits up; AstraZeneca, FTSE 100 slip; Trump trades higher; ASOS losses escalate

1. Primark owner ABF hikes dividend, buyback as profit jumps “We delivered a substantial improvement in profitability, excellent cash generation…

AstraZeneca sheds £15bn in value on weight loss drug data, China fraud report

AstraZeneca PLC (LSE:AZN) shed £15 billion in value on Tuesday following early data on its weight loss drugs and reports dozens…

GOLDMAN SACHS stuft ASTRAZENECA auf Buy

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Astrazeneca mit einem Kursziel von 16046 Pence…

UBS stuft ASTRAZENECA auf Sell

ZÜRICH (dpa-AFX Analyser) - Die schweizerische Großbank UBS hat die Einstufung für Astrazeneca auf "Sell" mit einem Kursziel von 11.300…

Total Voting Rights

1 November 2024 15:00 GMT Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

AstraZeneca says its China operations president under investigation

AstraZenecas China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending shares down…

AZN China President under investigation

This announcement contains inside information 30 October 2024 AstraZeneca China President currently under investigation Leon Wang, Executive Vice President International and AstraZeneca China…

AstraZeneca Receives CHMPs Approval for Wainzua in Europe

The CHMP recommends approval for AZNs Wainzua for treating polyneuropathy associated with hereditary transthyretin-mediated amyloidosis.…

Wainzua recommended for approval in the EU

21 October 2024 Wainzua (eplontersen) recommended for approval in the EU by CHMP for the treatment of adult patients with polyneuropathy associated…

US Rheumatologists and Dermatologists Report Over Half of their Dermatomyositis Patients Not Optimally Managed, According to Spherix Global Insights

Although CSL Behring’s Hizentra (IgPro20) is touted as a key pipeline agent to watch, rheumatologists currently prefer AstraZeneca’s Saphnelo (anifrolumab),…

The Zacks Analyst Blog Highlights AstraZeneca, Accenture, AT&T and National Presto Industries

AstraZeneca, Accenture, AT&T and National Presto Industries are part of the Zacks top Analyst Blog.…

Top Research Reports for AstraZeneca, Accenture & AT&T

Todays Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), Accenture plc (ACN) and AT&T…

AstraZeneca reports positive results for Airsupra v. albuterol study

…

AstraZeneca licenses lipid lowering Lp(a) asset

7 October 2024 AstraZeneca strengthens its cardiovascular pipeline with agreement for a pre-clinical novel lipid-lowering therapy AstraZeneca has entered into an exclusive…

AstraZeneca and Gilead Sciences merger would be the biggest in the pharma history

…

Avillion announces positive high-level results from Phase III BATURA trial with AstraZeneca’s inhaled anti-inflammatory medication Airsupra in asthma patients

London, UK, 7 October 2024 – Avillion Life Sciences Ltd (“Avillion”) announces that the ongoing BATURA Phase IIIb trial evaluating…

5 Large Drug Stocks to Watch From a Thriving Industry

Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), AstraZeneca (AZN),…

AstraZenecas Calquence sNDA Gets FDA Priority Tag for Expanded Use

The FDA grants priority review to AZNs sNDA for Calquence for untreated mantle cell lymphoma. A decision is expected in…

Total Voting Rights

1 October 2024 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

AstraZenecas Enhertu sBLA Gets FDA Priority Tag for Expanded Use

The FDA grants priority review to AZNs sBLA for Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer. A decision…

Novos Tough Month Key in Ending Health Stocks Winning Streak

European health-care stocks are set to snap their longest winning streak since March 2010, dragged down by concerns over Novo…

The Zacks Analyst Blog Highlights Toyota Motor, AstraZeneca, Chubb, Air T and Preformed Line Products

Toyota Motor, AstraZeneca, Chubb, Air T and Preformed Line Products are part of the Zacks top Analyst Blog.…

Tagrisso US approval in unresectable lung cancer

26 September 2024  Tagrisso approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer Based on LAURA Phase III trial results which showed Tagrisso extended…

Buy These 5 Big Drug Stocks to Boost Your Portfolios Health

Pfizer, Eli Lilly, AstraZeneca, Bayer and Sanofi can prove to be great additions to your portfolio.…

AZNs Tagrisso Gets FDA Nod for Expanded Use in NSCLC

The FDA approves AstraZenecas Tagrisso for treating unresectable, stage III EGFR-mutated non-small cell lung cancer.…

AstraZeneca Stock Up Almost 14% in 6 Months: Time to Buy?

AZNs key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga are likely to drive sales. It has several candidates with…

Top Stock Reports for Toyota, AstraZeneca & Chubb

Todays Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp. (TM), AstraZeneca PLC (AZN) and…

AstraZeneca PLC (AZN) Annual Deutsche Bank Leveraged Finance Conference (Transcript)

…

FIVE at FIVE: Another Rightmove bid; Gold hits fresh high; FTSE 100 up; More AstraZeneca woe, fuel prices fall

1. Rightmove receives third bid from genuinely disappointed REA Group This marks the third approach made by REA, following an…

Final OS results reported for TROPION-Breast01

23 September 2024 Datopotamab deruxtecan final overall survival results reported in patients with metastatic HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase…

US FDA approves AstraZenecas flu vaccine for self-administration By Reuters

US FDA approves AstraZenecas flu vaccine for self-administration…

Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ Drugs

FDA approves Lillys eczema drug, Ebglyss, and the expanded use of Novartis Kisqali, Mercks Keytruda and AstraZenecas Fasenra.…

BenevolentAI interims highlight progress and potential of AI-driven drug discovery

BenevolentAI (OTC:BAIVF), the AI-driven biopharma drug discovery working with the likes of AstraZeneca and Merck, today announced its interim results…

Fortune 500 giant will open bioanalytical laboratory in Gothenburg

Thermo Fisher Scientific will expand its bioanalytical presence in Europe and has chosen Gothenburg, Sweden, as a base for its…

FASENRA EGPA US FDA APPROVAL

18 September 2024 Fasenra approved in the US for eosinophilic granulomatosis with polyangiitis New indication supported by the MANDARA trial which showed…

AZN Gets FDA Nod for Fasenra Label Expansion in Rare Disease

The FDA okays AstraZenecas Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the second approved indication for…

AstraZeneca PLC (AZN) Meet the Management at ESMO 2024 Conference (Transcript)

…

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind…

Astrazeneca Aktie: Enttäuschende Studienergebnisse belasten Kurs

Die Astrazeneca-Aktie gerät unter Druck, nachdem die Deutsche Bank Research ihre Einschätzung von "Halten" auf "Verkaufen" herabgestuft und das Kursziel…

AstraZeneca Shares Set For Worst Week in 14 Months on Sell Calls

AstraZeneca Plc shares are on track for their biggest weekly decline since July 2023, after a disappointing update for the…

ANALYSE-FLASH: Deutsche Bank Research senkt Astrazeneca auf 'Sell'

FRANKFURT (dpa-AFX Broker) - Deutsche Bank Research hat Astrazeneca von "Hold" auf "Sell" abgestuft…

AstraZeneca: Upgrade

Wien (www.aktiencheck.de) - Rating-Update: Hans Engel, Analyst von Erste Group Research, stuft die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455,…